
Marshall Wace’s Integra LifeSciences IART Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $491K | Buy |
+39,988
| New | +$491K | ﹤0.01% | 2021 |
|
2024
Q2 | – | Sell |
-26,709
| Closed | -$947K | – | 2461 |
|
2024
Q1 | $947K | Buy |
26,709
+15,322
| +135% | +$543K | ﹤0.01% | 1466 |
|
2023
Q4 | $496K | Sell |
11,387
-25,583
| -69% | -$1.11M | ﹤0.01% | 1431 |
|
2023
Q3 | $1.41M | Sell |
36,970
-333,318
| -90% | -$12.7M | ﹤0.01% | 1165 |
|
2023
Q2 | $15.2M | Buy |
+370,288
| New | +$15.2M | 0.03% | 510 |
|
2022
Q1 | – | Sell |
-4,063
| Closed | -$272K | – | 2904 |
|
2021
Q4 | $272K | Buy |
+4,063
| New | +$272K | ﹤0.01% | 2387 |
|
2021
Q3 | – | Sell |
-28,856
| Closed | -$1.97M | – | 2588 |
|
2021
Q2 | $1.97M | Buy |
+28,856
| New | +$1.97M | 0.01% | 1139 |
|
2020
Q4 | – | Sell |
-12,603
| Closed | -$595K | – | 1871 |
|
2020
Q3 | $595K | Buy |
+12,603
| New | +$595K | ﹤0.01% | 1150 |
|
2020
Q2 | – | Sell |
-10,887
| Closed | -$486K | – | 1703 |
|
2020
Q1 | $486K | Buy |
+10,887
| New | +$486K | ﹤0.01% | 972 |
|
2019
Q4 | – | Sell |
-392,910
| Closed | -$23.6M | – | 1822 |
|
2019
Q3 | $23.6M | Sell |
392,910
-9,406
| -2% | -$565K | 0.19% | 116 |
|
2019
Q2 | $22.5M | Buy |
402,316
+211,100
| +110% | +$11.8M | 0.18% | 107 |
|
2019
Q1 | $10.7M | Buy |
191,216
+47,790
| +33% | +$2.66M | 0.1% | 240 |
|
2018
Q4 | $6.47M | Buy |
+143,426
| New | +$6.47M | 0.07% | 373 |
|
2015
Q4 | – | Sell |
-9,295
| Closed | -$554K | – | 1041 |
|
2015
Q3 | $554K | Sell |
9,295
-552
| -6% | -$32.9K | 0.01% | 723 |
|
2015
Q2 | $663K | Buy |
+9,847
| New | +$663K | 0.01% | 671 |
|